Elevance Health Raises 2026 Adjusted EPS Floor to $29 a Share

Elevance Health raised its 2026 adjusted earnings floor to $29 per share from $27 after third-quarter profit increased from a year earlier, and also lifted its cash flow outlook.

Adjusted diluted earnings per share rose 15.9% to $6.99 from $6.03 a year earlier. GAAP diluted earnings per share increased to $6.27 from $5.32. The quarter included a net non-operating benefit of $1.85 per share alongside improved operating performance.

Total revenue grew 1.4% to $51.429 billion. Operating revenue, a separate measure, rose 0.7% to $50.4 billion.

Elevance Health also raised its minimum 2026 GAAP diluted earnings forecast to $22 per share from $20.10. It increased its operating cash flow outlook to at least $6.5 billion from at least $6 billion. The previous floors were set after the company’s second-quarter results.

Carelon’s operating revenue rose 5% to $19.3 billion, and its operating gain increased 17% to $0.9 billion. Health Benefits operating revenue grew 3% to $43.4 billion, while its operating gain fell to $0.4 billion from $0.6 billion a year earlier.